All Stories

  1. Insulin receptorT1160 phosphorylation mediates renal cortical insulin resistance but not excess gluconeogenesis from glycerol
  2. Distinct effects of ketogenic and non-ketogenic weight-loss diets on hepatic steatosis and mitochondrial metabolism in MASLD
  3. High-fat diet ablates an insulin-responsive pool of GLUT4 glucose transporters in skeletal muscle
  4. Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitis
  5. Determinants of increased muscle insulin sensitivity of exercise-trained versus sedentary normal weight and overweight individuals
  6. Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver disease
  7. Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptorT1150 phosphorylation pathway
  8. Lysophosphatidic acid triggers inflammation in the liver and white adipose tissue in rat models of 1-acyl-sn-glycerol-3-phosphate acyltransferase 2 deficiency and overnutrition
  9. Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis
  10. Q-Flux: A method to assess hepatic mitochondrial succinate dehydrogenase, methylmalonyl-CoA mutase, and glutaminase fluxes in vivo
  11. Deletion of Jazf1 gene causes early growth retardation and insulin resistance in mice
  12. Brown adipose TRX2 deficiency activates mtDNA-NLRP3 to impair thermogenesis and protect against diet-induced insulin resistance
  13. Ethnic and sex differences in hepatic lipid content and related cardiometabolic parameters in lean individuals
  14. Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis
  15. Sex‐ and strain‐specific effects of mitochondrial uncoupling on age‐related metabolic diseases in high‐fat diet‐fed mice
  16. MMAB promotes negative feedback control of cholesterol homeostasis
  17. Point: An alternative hypothesis for why exposure to static magnetic and electric fields treats type 2 diabetes
  18. Reply to Carter et al.: An alternative hypothesis for why exposure to static magnetic and electric fields treats type 2 diabetes
  19. Mechanisms and disease consequences of nonalcoholic fatty liver disease
  20. An update on brown adipose tissue biology: a discussion of recent findings
  21. Short-term overnutrition induces white adipose tissue insulin resistance through sn-1,2-diacylglycerol/PKCε/insulin receptor Thr1160 phosphorylation
  22. A feed-forward regulatory loop in adipose tissue promotes signaling by the hepatokine FGF21
  23. Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance
  24. Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice
  25. Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks
  26. Cellular and Molecular Mechanisms of Metformin Action
  27. The omentum of obese girls harbors small adipocytes and browning transcripts
  28. Leptin mediates postprandial increases in body temperature through hypothalamus–adrenal medulla–adipose tissue crosstalk
  29. Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications
  30. Regulation of hepatic mitochondrial oxidation by glucose-alanine cycling during starvation in humans
  31. GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)
  32. Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action
  33. TFAM Enhances Fat Oxidation and Attenuates High Fat Diet Induced Insulin Resistance in Skeletal Muscle
  34. Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function
  35. Altered In Vivo Lipid Fluxes and Cell Dynamics in Subcutaneous Adipose Tissues Are Associated With the Unfavorable Pattern of Fat Distribution in Obese Adolescent Girls
  36. Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats
  37. Mechanisms of Insulin Action and Insulin Resistance
  38. PKCε contributes to lipid-induced insulin resistance through cross talk with p70S6K and through previously unknown regulators of insulin signaling
  39. The circulating metabolome of human starvation
  40. Lacteal junction zippering protects against diet-induced obesity
  41. Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
  42. Deciphering the Role of Lipid Droplets in Cardiovascular Disease
  43. Loss of Nucleobindin-2 Causes Insulin Resistance in Obesity without Impacting Satiety or Adiposity
  44. Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer
  45. Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents
  46. Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia
  47. The link between insulin and fatty liver
  48. Effect of a Controlled-Release Mitochondrial Protonophore (CRMP) on Healthspan and Lifespan in Mice
  49. Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis
  50. The Role of Leptin in Maintaining Plasma Glucose During Starvation
  51. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents
  52. In vivo studies on the mechanism of methylene cyclopropyl acetic acid and methylene cyclopropyl glycine-induced hypoglycemia
  53. Publisher Correction: Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA)
  54. Skeletal Muscle–Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance
  55. Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation
  56. Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes
  57. Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
  58. Mechanism by which arylamine N -acetyltransferase 1 ablation causes insulin resistance in mice
  59. Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling
  60. Retinol saturase modulates lipid metabolism and the production of reactive oxygen species
  61. Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms
  62. Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA)
  63. Absence of Carbohydrate Response Element Binding Protein in Adipocytes Causes Systemic Insulin Resistance and Impairs Glucose Transport
  64. Regulation of hepatic glucose metabolism in health and disease
  65. Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance
  66. The human longevity gene homolog INDY and interleukin-6 interact in hepatic lipid metabolism
  67. Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
  68. Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
  69. Mitochondrial-Targeted Catalase Protects Against High-Fat Diet–Induced Muscle Insulin Resistance by Decreasing Intramuscular Lipid Accumulation
  70. A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice
  71. Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes
  72. A Non-invasive Method to Assess Hepatic Acetyl-CoA In Vivo
  73. Adipocyte JAK2 mediates growth hormone–induced hepatic insulin resistance
  74. Mechanism for leptin’s acute insulin-independent effect to reverse diabetic ketoacidosis
  75. Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism
  76. Insulin Resistance in Type 2 Diabetes
  77. Hepatic inositol 1,4,5 trisphosphate receptor type 1 mediates fatty liver
  78. Resolution of non-alcoholic steatohepatitis after growth hormone replacement in a pediatric liver transplant patient with panhypopituitarism
  79. Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance
  80. CD301b + Mononuclear Phagocytes Maintain Positive Energy Balance through Secretion of Resistin-like Molecule Alpha
  81. MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels
  82. Imeglimin lowers glucose primarily by amplifying glucose-stimulated insulin secretion in high-fat-fed rodents
  83. Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice
  84. Assessment of Hepatic Mitochondrial Oxidation and Pyruvate Cycling in NAFLD by 13 C Magnetic Resonance Spectroscopy
  85. Hypophosphatemia promotes lower rates of muscle ATP synthesis
  86. XBP1s Is an Anti-lipogenic Protein
  87. Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome
  88. Argininosuccinate synthetase regulates hepatic AMPK linking protein catabolism and ureagenesis to hepatic lipid metabolism
  89. Disruption of Adipose Rab10-Dependent Insulin Signaling Causes Hepatic Insulin Resistance
  90. Propionate Increases Hepatic Pyruvate Cycling and Anaplerosis and Alters Mitochondrial Metabolism
  91. Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosis
  92. Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice
  93. AMPK is critical for mitochondrial function during reperfusion after myocardial ischemia
  94. 17α-Estradiol Alleviates Age-related Metabolic and Inflammatory Dysfunction in Male Mice Without Inducing Feminization
  95. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
  96. Metabolic Syndrome
  97. A Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents
  98. Second-generation antisense oligonucleotides against  -catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance
  99. Prevention of diet-induced hepatic steatosis and hepatic insulin resistance by second generation antisense oligonucleotides targeted to the longevity gene mIndy (Slc13a5)
  100. Macrophage-specificde NovoSynthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity
  101. Correction for Petersen et al., Effect of aging on muscle mitochondrial substrate utilization in humans
  102. Mechanism by which caloric restriction improves insulin sensitivity in sedentary obese adults
  103. Effect of aging on muscle mitochondrial substrate utilization in humans
  104. Type 2 diabetes mellitus
  105. Short-term food restriction followed by controlled refeeding promotes gorging behavior, enhances fat deposition, and diminishes insulin sensitivity in mice
  106. FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic–pituitary–adrenal axis
  107. Pathogenesis of type 2 diabetes mellitus
  108. Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
  109. Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes
  110. Response to Burgess
  111. Reply to Constantin-Teodosiu et al.: Mice with genetic PDH activation are not protected from high-fat diet–induced muscle insulin resistance
  112. Neuronal UCP1 expression suggests a mechanism for local thermogenesis during hibernation
  113. Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids
  114. Acetylation of TUG Protein Promotes the Accumulation of GLUT4 Glucose Transporters in an Insulin-responsive Intracellular Compartment
  115. ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content
  116. Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
  117. Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
  118. Inositol 1,4,5-trisphosphate receptor type II (InsP3R-II) is reduced in obese mice, but metabolic homeostasis is preserved in mice lacking InsP3R-II
  119. An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
  120. The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells
  121. Genetic activation of pyruvate dehydrogenase alters oxidative substrate selection to induce skeletal muscle insulin resistance
  122. Hepatic Mitogen-Activated Protein Kinase Phosphatase 1 Selectively Regulates Glucose Metabolism and Energy Homeostasis
  123. Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice
  124. Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
  125. Mitochondrial GTP Insensitivity Contributes to Hypoglycemia in Hyperinsulinemia Hyperammonemia by Inhibiting Glucagon Release
  126. PKCλ Haploinsufficiency Prevents Diabetes by a Mechanism Involving Alterations in Hepatic Enzymes
  127. Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
  128. Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis
  129. Tissue-Specific Differences in the Development of Insulin Resistance in a Mouse Model for Type 1 Diabetes
  130. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
  131. Cyclin D1–Cdk4 controls glucose metabolism independently of cell cycle progression
  132. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
  133. Ceramide-Activated Phosphatase Mediates Fatty Acid–Induced Endothelial VEGF Resistance and Impaired Angiogenesis
  134. Muscle-specific activation of Ca2+/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice
  135. Early Life Exposure to Maternal Insulin Resistance Has Persistent Effects on Hepatic NAFLD in Juvenile Nonhuman Primates
  136. Ostα−/− mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity
  137. A Role for Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) in the Regulation of Hepatic Gluconeogenesis
  138. Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
  139. Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
  140. Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat Switch
  141. Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic 13C magnetic resonance spectroscopy
  142. Treating fatty liver and insulin resistance
  143. The Mammalian INDY Homolog Is Induced by CREB in a Rat Model of Type 2 Diabetes
  144. Reversal of Hypertriglyceridemia, Fatty Liver Disease, and Insulin Resistance by a Liver-Targeted Mitochondrial Uncoupler
  145. PP2A inhibition results in hepatic insulin resistance despite Akt2 activation
  146. A β-Peptide Agonist of the GLP-1 Receptor, a Class B GPCR
  147. Impairment of insulin-stimulated glucose transport and ERK activation by adipocyte-specific knockout of PKC-λ produces a phenotype characterized by diminished adiposity and enhanced insulin suppression of hepatic gluconeogenesis
  148. Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice
  149. Lipid-induced hepatic insulin resistance
  150. Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo
  151. Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways
  152. Enhanced Fasting Glucose Turnover in Mice with Disrupted Action of TUG Protein in Skeletal Muscle
  153. Increased Brain Lactate Concentrations Without Increased Lactate Oxidation During Hypoglycemia in Type 1 Diabetic Individuals
  154. cAMP-responsive Element-binding Protein (CREB)-regulated Transcription Coactivator 2 (CRTC2) Promotes Glucagon Clearance and Hepatic Amino Acid Catabolism to Regulate Glucose Homeostasis
  155. Fish Oil Selectively Improves Heart Function in a Mouse Model of Lipid-induced Cardiomyopathy
  156. Role of caspase-1 in regulation of triglyceride metabolism
  157. Cellular Mechanism by Which Estradiol Protects Female Ovariectomized Mice From High-Fat Diet-Induced Hepatic and Muscle Insulin Resistance
  158. Mechanisms Underlying the Onset of Oral Lipid-Induced Skeletal Muscle Insulin Resistance in Humans
  159. Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance
  160. Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats
  161. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance
  162. The Role of the Carbohydrate Response Element-Binding Protein in Male Fructose-Fed Rats
  163. Decreased Transcription of ChREBP- /  Isoforms in Abdominal Subcutaneous Adipose Tissue of Obese Adolescents With Prediabetes or Early Type 2 Diabetes: Associations With Insulin Resistance and Hyperglycemia
  164. The Deacetylase Sirt6 Activates the Acetyltransferase GCN5 and Suppresses Hepatic Gluconeogenesis
  165. 31P-Magnetization Transfer Magnetic Resonance Spectroscopy Measurements of In Vivo Metabolism
  166. Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism
  167. Chemical and genetic evidence for the involvement of Wnt antagonist Dickkopf2 in regulation of glucose metabolism
  168. Development of insulin resistance in mice lacking PGC-1α in adipose tissues
  169. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
  170. Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance
  171. Reversal of muscle insulin resistance by weight reduction in young, lean, insulin-resistant offspring of parents with type 2 diabetes
  172. Mechanisms for Insulin Resistance: Common Threads and Missing Links
  173. Regulation of Mitochondrial Biogenesis by Lipoprotein Lipase in Muscle of Insulin-Resistant Offspring of Parents With Type 2 Diabetes
  174. Thyroid Hormone Receptor-α Gene Knockout Mice Are Protected from Diet-Induced Hepatic Insulin Resistance
  175. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
  176. Low Density Lipoprotein (LDL) Receptor-related Protein 6 (LRP6) Regulates Body Fat and Glucose Homeostasis by Modulating Nutrient Sensing Pathways and Mitochondrial Energy Expenditure
  177. A guide to analysis of mouse energy metabolism
  178. Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats
  179. Dissociation of Inositol-requiring Enzyme (IRE1α)-mediated c-Jun N-terminal Kinase Activation from Hepatic Insulin Resistance in Conditional X-box-binding Protein-1 (XBP1) Knock-out Mice
  180. SirT1 Regulates Adipose Tissue Inflammation
  181. Dissociation of the Glucose and Lipid Regulatory Functions of FoxO1 by Targeted Knockin of Acetylation-Defective Alleles in Mice
  182. Impact of CD1d Deficiency on Metabolism
  183. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
  184. Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
  185. Indy knockdown in mice mimics elements of dietary restriction
  186. Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance
  187. Influence of the Hepatic Eukaryotic Initiation Factor 2α (eIF2α) Endoplasmic Reticulum (ER) Stress Response Pathway on Insulin-mediated ER Stress and Hepatic and Peripheral Glucose Metabolism
  188. Deletion of the Mammalian INDY Homolog Mimics Aspects of Dietary Restriction and Protects against Adiposity and Insulin Resistance in Mice
  189. Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals
  190. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner
  191. GPA protects the nigrostriatal dopamine system by enhancing mitochondrial function
  192. Desnutrin/ATGL Is Regulated by AMPK and Is Required for a Brown Adipose Phenotype
  193. Magnetic Resonance Spectroscopy Studies of Human Metabolism
  194. Lysophosphatidic Acid Activates Peroxisome Proliferator Activated Receptor-γ in CHO Cells That Over-Express Glycerol 3-Phosphate Acyltransferase-1
  195. FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
  196. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
  197. Regulation of hepatic fat and glucose oxidation in rats with lipid-induced hepatic insulin resistance
  198. Characterization of the Hyperphagic Response to Dietary Fat in the MC4R Knockout Mouse
  199. SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
  200. Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance
  201. Diabetes in Mice With Selective Impairment of Insulin Action in Glut4-Expressing Tissues
  202. Mouse Cardiac Acyl Coenzyme A Synthetase 1 Deficiency Impairs Fatty Acid Oxidation and Induces Cardiac Hypertrophy
  203. Regulation of Hepatic Glucose Uptake
  204. Sirtuin-1 regulation of mammalian metabolism
  205. Knockdown of the gene encoding Drosophila tribbles homologue 3 (Trib3) improves insulin sensitivity through peroxisome proliferator-activated receptor-γ (PPAR-γ) activation in a rat model of insulin resistance
  206. Targeted Expression of Catalase to Mitochondria Prevents Age-Associated Reductions in Mitochondrial Function and Insulin Resistance
  207. A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain
  208. The Contribution of Blood Lactate to Brain Energy Metabolism in Humans Measured by Dynamic 13C Nuclear Magnetic Resonance Spectroscopy
  209. PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation
  210. Downregulation ofADIPOQandPPARγ2Gene Expression in Subcutaneous Adipose Tissue of Obese Adolescents With Hepatic Steatosis
  211. Chylomicron- and VLDL-derived Lipids Enter the Heart through Different Pathways
  212. Cellularity and Adipogenic Profile of the Abdominal Subcutaneous Adipose Tissue From Obese Adolescents: Association With Insulin Resistance and Hepatic Steatosis
  213. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents
  214. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance
  215. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice
  216. The Role of Muscle Insulin Resistance in the Pathogenesis of Atherogenic Dyslipidemia and Nonalcoholic Fatty Liver Disease Associated with the Metabolic Syndrome
  217. Regulation of mitochondrial biogenesis
  218. Lipid-induced insulin resistance: unravelling the mechanism
  219. Uncoupling Protein-2 Decreases the Lipogenic Actions of Ghrelin
  220. Resistance to High-Fat Diet-Induced Obesity and Insulin Resistance in Mice with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
  221. Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia
  222. Effects of Pioglitazone on Intramyocellular Fat Metabolism in Patients with Type 2 Diabetes Mellitus
  223. Diacylglycerol-mediated insulin resistance
  224. Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease
  225. Deletion of the  -Arrestin Protein Txnip in Mice Promotes Adiposity and Adipogenesis While Preserving Insulin Sensitivity
  226. Glycerol-3-Phosphate Acyltransferase 1 Deficiency in ob/ob Mice Diminishes Hepatic Steatosis but Does Not Protect Against Insulin Resistance or Obesity
  227. PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis
  228. Prevention of Hepatic Steatosis and Hepatic Insulin Resistance by Knockdown of cAMP Response Element-Binding Protein
  229. MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice
  230. Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin Resistance
  231. Altered Brain Mitochondrial Metabolism in Healthy Aging as Assessed by in vivo Magnetic Resonance Spectroscopy
  232. Paradoxical Coupling of Triglyceride Synthesis and Fatty Acid Oxidation in Skeletal Muscle Overexpressing DGAT1
  233. Liver-specific Loss of Long Chain Acyl-CoA Synthetase-1 Decreases Triacylglycerol Synthesis and β-Oxidation and Alters Phospholipid Fatty Acid Composition
  234. Phosphoenolpyruvate Cycling via Mitochondrial Phosphoenolpyruvate Carboxykinase Links Anaplerosis and Mitochondrial GTP with Insulin Secretion
  235. Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes
  236. SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats
  237. Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans
  238. Mitochondrial Dysfunction Contributes to Impaired Insulin Secretion in INS-1 Cells with Dominant-negative Mutations of HNF-1α and in HNF-1α-deficient Islets
  239. Sensitivity of Lipid Metabolism and Insulin Signaling to Genetic Alterations in Hepatic Peroxisome Proliferator-Activated Receptor-  Coactivator-1  Expression
  240. STAT3 inhibition of gluconeogenesis is downregulated by SirT1
  241. The Role of Peroxisome Proliferator-Activated Receptor γ Coactivator-1 β in the Pathogenesis of Fructose-Induced Insulin Resistance
  242. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency
  243. Adipose Overexpression of Desnutrin Promotes Fatty Acid Use and Attenuates Diet-Induced Obesity
  244. Increased Energy Expenditure and Insulin Sensitivity in the High Bone Mass ΔFosB Transgenic Mice
  245. METABOLISM
  246. Chapter 21 Assessment of In Vivo Mitochondrial Metabolism by Magnetic Resonance Spectroscopy
  247. Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism
  248. N-acylphosphatidylethanolamine, a Gut- Derived Circulating Factor Induced by Fat Ingestion, Inhibits Food Intake
  249. Increased substrate oxidation and mitochondrial uncoupling in skeletal muscle of endurance-trained individuals
  250. Resistance to High-Fat Diet-Induced Obesity but Exacerbated Insulin Resistance in Mice Overexpressing Preadipocyte Factor-1 (Pref-1): A New Model of Partial Lipodystrophy
  251. UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals
  252. Muscle-Specific IRS-1 Ser->Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle
  253. Reduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant mice
  254. Brain-specific carnitine palmitoyl-transferase-1c: role in CNS fatty acid metabolism, food intake, and body weight
  255. Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL
  256. A Prevalent Variant in PPP1R3A Impairs Glycogen Synthesis and Reduces Muscle Glycogen Content in Humans and Mice
  257. Dual role of proapoptotic BAD in insulin secretion and beta cell survival
  258. Regulation of hypothalamic malonyl-CoA by central glucose and leptin
  259. Abnormal glucose homeostasis in skeletal muscle–specific PGC-1α knockout mice reveals skeletal muscle–pancreatic β cell crosstalk
  260. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance
  261. Continuous fat oxidation in acetyl–CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity
  262. Obesity-associated improvements in metabolic profile through expansion of adipose tissue
  263. Muscle-specific knockout of PKC-λ impairs glucose transport and induces metabolic and diabetic syndromes
  264. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
  265. Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance
  266. Interethnic Differences in Muscle, Liver and Abdominal Fat Partitioning in Obese Adolescents
  267. Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but NotDGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance
  268. Synaptic Glutamate Release by Ventromedial Hypothalamic Neurons Is Part of the Neurocircuitry that Prevents Hypoglycemia
  269. Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance
  270. Mitochondrial GTP Regulates Glucose-Stimulated Insulin Secretion
  271. Hepatic Overexpression of Glycerol-sn-3-phosphate Acyltransferase 1 in Rats Causes Insulin Resistance
  272. Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo
  273. Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease
  274. Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Patients
  275. Aging-Associated Reductions in AMP-Activated Protein Kinase Activity and Mitochondrial Biogenesis
  276. n-3 Fatty Acids Preserve Insulin Sensitivity In Vivo in a Peroxisome Proliferator-Activated Receptor- -Dependent Manner
  277. Measurements of the anaplerotic rate in the human cerebral cortex using13C magnetic resonance spectroscopy and [1-13C] and [2-13C] glucose
  278. Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals
  279. Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance
  280. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
  281. Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction
  282. Cytosolic and Mitochondrial Malic Enzyme Isoforms Differentially Control Insulin Secretion
  283. Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle
  284. Immunoneutralization of Endogenous Glucagon Reduces Hepatic Glucose Output and Improves Long-Term Glycemic Control in Diabetic ob/ob Mice
  285. Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1
  286. Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity
  287. Regulation of Metabolic Responses by Adipocyte/ Macrophage Fatty Acid-Binding Proteins in Leptin-Deficient Mice
  288. Targeting Foxo1 in Mice Using Antisense Oligonucleotide Improves Hepatic and Peripheral Insulin Action
  289. The role of AMP-activated protein kinase in mitochondrial biogenesis
  290. Introduction
  291. Etiology of Insulin Resistance
  292. Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice
  293. The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis
  294. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
  295. Fish Oil Regulates Adiponectin Secretion by a Peroxisome Proliferator-Activated Receptor- -Dependent Mechanism in Mice
  296. Increased Brain Monocarboxylic Acid Transport and Utilization in Type 1 Diabetes
  297. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2
  298. New Insights into the Pathogenesis of Insulin Resistance in Humans Using Magnetic Resonance Spectroscopy
  299. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents
  300. Effect of a Sustained Reduction in Plasma Free Fatty Acid Concentration on Intramuscular Long-Chain Fatty Acyl-CoAs and Insulin Action in Type 2 Diabetic Patients
  301. The Role of Intramyocellular Lipids during Hypoglycemia in Patients with Intensively Treated Type 1 Diabetes
  302. MRS Studies of the Role of the Muscle Glycogen Synthesis Pathway in the Pathophysiology of Type 2 Diabetes
  303. Decreased Insulin-Stimulated ATP Synthesis and Phosphate Transport in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Parents
  304. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice
  305. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart
  306. The “Obese Insulin-Sensitive” Adolescent: Importance of Adiponectin and Lipid Partitioning
  307. Adipocyte-Specific Overexpression of FOXC2 Prevents Diet-Induced Increases in Intramuscular Fatty Acyl CoA and Insulin Resistance
  308. Mitochondrial Glycerol-3-phosphate Acyltransferase-1 Is Essential in Liver for the Metabolism of Excess Acyl-CoAs
  309. Mechanisms of Insulin Resistance in Humans and Possible Links With Inflammation
  310. Reversal of Nonalcoholic Hepatic Steatosis, Hepatic Insulin Resistance, and Hyperglycemia by Moderate Weight Reduction in Patients With Type 2 Diabetes
  311. Mitochondrial Dysfunction and Type 2 Diabetes
  312. Alterations in Postprandial Hepatic Glycogen Metabolism in Type 2 Diabetes
  313. A Cluster of Metabolic Defects Caused by Mutation in a Mitochondrial tRNA
  314. Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
  315. PKC-θ knockout mice are protected from fat-induced insulin resistance
  316. 13C NMR Isotopomer Analysis of Anaplerotic Pathways in INS-1 Cells
  317. 40th EASD Annual Meeting of the European Association for the Study of Diabetes
  318. Unraveling the Cellular Mechanism of Insulin Resistance in Humans: New Insights from Magnetic Resonance Spectroscopy
  319. Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease
  320. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation
  321. Transgenic Overexpression of Protein-tyrosine Phosphatase 1B in Muscle Causes Insulin Resistance, but Overexpression with Leukocyte Antigen-related Phosphatase Does Not Additively Impair Insulin Action
  322. Effects of Rexinoids on Glucose Transport and Insulin-mediated Signaling in Skeletal Muscles of Diabetic (db/db) Mice
  323. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle
  324. Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
  325. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance
  326. Liver fatty acid-binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPAR-  in fasting mice
  327. Effects of depletion exercise and light training on muscle glycogen supercompensation in men
  328. Cellular mechanism of insulin resistance: potential links with inflammation
  329. Genetic Modulation of PPARγ Phosphorylation Regulates Insulin Sensitivity
  330. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning
  331. Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise
  332. Insulin Resistance in Tetracycline-Repressible Munc18c Transgenic Mice
  333. Phosphoinositide profiling in complex lipid mixtures using electrospray ionization mass spectrometry
  334. Differential Effects of Rosiglitazone on Skeletal Muscle and Liver Insulin Resistance in A-ZIP/F-1 Fatless Mice
  335. Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
  336. Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke
  337. Low Adiponectin Levels in Adolescent Obesity: A Marker of Increased Intramyocellular Lipid Accumulation
  338. Pioglitazone Improves Insulin Sensitivity Among Nondiabetic Patients With a Recent Transient Ischemic Attack or Ischemic Stroke
  339. Defective Activation of Skeletal Muscle and Adipose Tissue Lipolysis in Type 1 Diabetes Mellitus during Hypoglycemia
  340. Skeletal muscle lipid metabolism with obesity
  341. Local Lactate Perfusion of the Ventromedial Hypothalamus Suppresses Hypoglycemic Counterregulation
  342. A comparison of 13C NMR measurements of the rates of glutamine synthesis and the tricarboxylic acid cycle during oral and intravenous administration of [1-13C]glucose
  343. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation
  344. Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle
  345. AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat
  346. Effect of Weight Loss on Insulin Sensitivity and Intramuscular Long-Chain Fatty Acyl-CoAs in Morbidly Obese Subjects
  347. Effects of a Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-Stimulated Glucose Metabolism in Zucker Diabetic Fatty (fa/fa) Rats
  348. Nonalcoholic Fatty Liver Disease
  349. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus
  350. Fatty Acid Infusion Selectively Impairs Insulin Action on Akt1 and Protein Kinase C lambda /zeta but Not on Glycogen Synthase Kinase-3
  351. Adrenalectomy Improves Diabetes in A-ZIP/F-1 Lipoatrophic Mice by Increasing Both Liver and Muscle Insulin Sensitivity
  352. [2,4-13C2]-β-Hydroxybutyrate Metabolism in Human Brain
  353. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction
  354. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
  355. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
  356. Assessment of Skeletal Muscle Triglyceride Content by 1H Nuclear Magnetic Resonance Spectroscopy in Lean and Obese Adolescents: Relationships to Insulin Sensitivity, Total Body Fat, and Central Adiposity
  357. Astroglial Contribution to Brain Energy Metabolism in Humans Revealed by13C Nuclear Magnetic Resonance Spectroscopy: Elucidation of the Dominant Pathway for Neurotransmitter Glutamate Repletion and Measurement of Astrocytic Oxidative Metabolism
  358. The Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetes
  359. Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content
  360. Inclusion of Low Amounts of Fructose With an Intraduodenal Glucose Load Markedly Reduces Postprandial Hyperglycemia and Hyperinsulinemia in the Conscious Dog
  361. Hepatic Glycogen Metabolism in Type 1 Diabetes After Long-Term Near Normoglycemia
  362. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis
  363. Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle
  364. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
  365. Prevention of fat-induced insulin resistance by salicylate
  366. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4
  367. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
  368. Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBbeta )
  369. Stimulating Effects of Low-Dose Fructose on Insulin-Stimulated Hepatic Glycogen Synthesis in Humans
  370. Uncoupling Protein-2 Negatively Regulates Insulin Secretion and Is a Major Link between Obesity, β Cell Dysfunction, and Type 2 Diabetes
  371. Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance
  372. Contribution of net hepatic glycogen synthesis to disposal of an oral glucose load in humans
  373. Effect of 5-Aminoimidazole-4-Carboxamide-1- -D-Ribofuranoside Infusion on In Vivo Glucose and Lipid Metabolism in Lean and Obese Zucker Rats
  374. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance
  375. In VivoEffects of Uncoupling Protein-3 Gene Disruption on Mitochondrial Energy Metabolism
  376. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
  377. Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways
  378. Lipid-dependent control of hepatic glycogen stores in healthy humans
  379. Nuclear Magnetic Resonance Studies of Hepatic Glucose Metabolism in Humans
  380. Mechanism by which metformin reduces glucose production in type 2 diabetes
  381. 13C/31P NMR Assessment of Mitochondrial Energy Coupling in Skeletal Muscle of Awake Fed and Fasted Rats
  382. Contrasting Effects of IRS-1VersusIRS-2 Gene Disruption on Carbohydrate and Lipid Metabolismin Vivo
  383. Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice
  384. Cellular mechanisms of insulin resistance
  385. Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic Dysfunction
  386. Regulation of myocardial [13C]glucose metabolism in conscious rats
  387. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle
  388. Effects of Caffeine on Muscle Glycogen Utilization and the Neuroendocrine Axis during Exercise
  389. Assessment of mitochondrial energy coupling in vivo by 13 C/ 31 P NMR
  390. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans
  391. Mechanism of troglitazone action in type 2 diabetes
  392. Mechanism of muscle glycogen autoregulation in humans
  393. Transgenic mice overexpressing GLUT-1 protein in muscle exhibit increased muscle glycogenesis after exercise
  394. Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice
  395. Persistent Changes in Myocardial Glucose Metabolism In Vivo During Reperfusion of a Limited-Duration Coronary Occlusion
  396. Glycogen loading alters muscle glycogen resynthesis after exercise
  397. Intramuscular Glycogen and Intramyocellular Lipid Utilization during Prolonged Exercise and Recovery in Man: A 13C and 1H Nuclear Magnetic Resonance Spectroscopy Study
  398. Spectroscopic imaging of glutamate C4 turnover in human brain
  399. Intense exercise stimulates albumin synthesis in the upright posture
  400. Impaired Glucose Transport as a Cause of Decreased Insulin-Stimulated Muscle Glycogen Synthesis in Type 2 Diabetes
  401. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13 C NMR
  402. Cellular mechanisms of insulin resistance in humans
  403. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade
  404. Regulation of myocardial glucose uptake and transport during ischemia and energetic stress
  405. Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats
  406. APPLICATIONS OF NMR SPECTROSCOPY TO STUDY MUSCLE GLYCOGEN METABOLISM IN MAN
  407. Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity
  408. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1 H NMR spectroscopy study
  409. NMR Studies on the Mechanism of Insulin Resistance
  410. Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study
  411. Additive Effects of Hyperinsulinemia and Ischemia on Myocardial GLUT1 and GLUT4 Translocation In Vivo
  412. Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
  413. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.
  414. 13C/31P NMR studies on the mechanism of insulin resistance in obesity
  415. Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis
  416. Disruption of IRS-2 causes type 2 diabetes in mice
  417. Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus
  418. Regulation of exogenous and endogenous glucose metabolism by insulin and acetoacetate in the isolated working rat heart. A three tracer study of glycolysis, glycogen metabolism, and glucose oxidation.
  419. In vivo NMR investigation of intramuscular glucose metabolism in conscious rats
  420. Metabolic Defects in Lean Nondiabetic Offspring of NIDDM Parents: A Cross-Sectional Study
  421. Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus.
  422. 13C and31P NMR Studies on the Effects of Increased Plasma Free Fatty Acids on Intramuscular Glucose Metabolism in the Awake Rat
  423. Low-Flow Ischemia Leads to Translocation of Canine Heart GLUT-4 and GLUT-1 Glucose Transporters to the Sarcolemma In Vivo
  424. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats.
  425. The Effect of Leptin Is Enhanced by Microinjection Into the Ventromedial Hypothalamus
  426. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria.
  427. Time course of the defective α-cell response to hypoglycemia in diabetic BB rats
  428. Increased Glucose Transport–Phosphorylation and Muscle Glycogen Synthesis after Exercise Training in Insulin-Resistant Subjects
  429. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects.
  430. Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia.
  431. Noninvasive assessment of hepatic triglyceride content in humans with13C nuclear magnetic resonance spectroscopy
  432. Mechanism of free fatty acid-induced insulin resistance in humans.
  433. NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise.
  434. The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.
  435. Contribution of net hepatic glycogenolysis to glucose production during the early postprandial period
  436. Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects.
  437. Mass and Positional Isotopomer Analysis of Glucose Metabolism in Periportal and Pericentral Hepatocytes
  438. Triiodothyronine treatment increases substrate cycling between pyruvate carboxylase and malic enzyme in perfused rat liver
  439. Central adiposity and its metabolic correlates in obese adolescent girls
  440. Islet Phosphoinositide Hydrolysis and Insulin Secretory Responses from Prediabetic fA/fA ZDF Rats
  441. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus.
  442. Contribution of Hepatic Glycogenolysis to Glucose Production in Humans in Response to a Physiological Increase in Plasma Glucagon Concentration
  443. Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study.
  444. Local Ventromedial Hypothalamus Glucopenia Triggers Counterregulatory Hormone Release
  445. Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice.
  446. 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus.
  447. Substrate cycling between pyruvate and oxaloacetate in awake normal and 3,3'-5-triiodo-L-thyronine-treated rats
  448. Effects of puberty and diabetes on metabolism of insulin-sensitive fuels
  449. Validation of13C NMR measurements of liver glycogenin vivo
  450. Liver glycogen turnover in fed and fasted humans
  451. Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.
  452. Human muscle glycogen resynthesis after exercise: insulin-dependent and -independent phases
  453. In vivo regulation of rat muscle glycogen resynthesis after intense exercise
  454. Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits.
  455. Temporal changes in insulin resistance and secretion in 24-h-fasted conscious pregnant rats
  456. Inhibitory Effect of Pregnancy on Counterregulatory Hormone Responses to Hypoglycemia in Awake Rat
  457. Effect of hepatic nerves on disposition of an intraduodenal glucose load
  458. Direct measurement of change in muscle glycogen concentration after a mixed meal in normal subjects
  459. Comparative Effects of Monomethylsuccinate and Glucose on Insulin Secretion from Perifused Rat Islets
  460. Enhancement of the gluconeogenic flux of hepatic glycogen repletion by a phenacyl imidazolium compound in vivo
  461. Cerebral Lactate Turnover after Electroshock: In vivo Measurements by 1H/13C Magnetic Resonance Spectroscopy
  462. Immunocytochemical localization of alpha-protein kinase C in rat pancreatic beta-cells during glucose-induced insulin secretion
  463. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study.
  464. Pathways of glycogen repletion
  465. Detection and assignment of the glucose signal in1h nmr difference spectra of the human brain
  466. Validation of13c nmr measurement of human skeletal muscle glycogen by direct biochemical assay of needle biopsy samples
  467. Simultaneous Insulinlike Growth Factor I and Insulin Resistance in Obese Zucker Rats
  468. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus.
  469. Direct measurement of brain glucose concentrations in humans by 13C NMR spectroscopy.
  470. Hypopituitarism associated with a hypothalamic CMV infection in a patient with AIDS
  471. N.m.r. studies of muscle glycogen synthesis in normal and non-insulin-dependent diabetic subjects
  472. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR
  473. Localized proton NMR observation of [3-13C] lactate in stroke after [1-13C] glucose infusion
  474. The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats
  475. Sources of carbon for hepatic glycogen synthesis in the conscious dog.
  476. Differential effect of hyperglycemia and hyperinsulinemia on pathways of hepatic glycogen repletion
  477. Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats
  478. Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression.
  479. Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans.
  480. Effect of metformin treatment on insulin action in diabetic rats: In vivo and in vitro correlations
  481. Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance Spectroscopy
  482. Chronicin VivoHyperglycemia Impairs Phosphoinositide Hydrolysis and Insulin Release in Isolated Perifused Rat Islets*
  483. Influence of the route of glucose administration on hepatic glycogen repletion
  484. Effect of dietary protein on in vivo insulin action and liver glycogen repletion
  485. Direct observation of glycogen synthesis in human muscle with 13C NMR.
  486. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.
  487. Physiological Role of Cholecystokinin in Meal-Induced Insulin Secretion in Conscious Rats: Studies With L 364718, A Specific Inhibitor of CCK-Receptor Binding
  488. Quantitative analysis of glycogen repletion by nuclear magnetic resonance spectroscopy in the conscious rat.
  489. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats.
  490. Plasma Level of 13,14-Dihydro-15-keto-PGE2 in Patients With Diabetic Ketoacidosis and in Normal Fasting Subjects
  491. Metabolic Response to Three Years of Continuous, Basal Rate Intravenous Insulin Infusion in Type II Diabetic Patients*
  492. Mechanism of liver glycogen repletion in vivo by nuclear magnetic resonance spectroscopy.
  493. A 1H NMR technique for observing metabolite signals in the spectrum of perfused liver.
  494. Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man.
  495. 23Na and 39K NMR studies of ion transport in human erythrocytes.
  496. Nuclear magnetic resonance spectroscopy in diagnostic and investigative medicine.
  497. Implantable Insulin Infusion Devices
  498. Differential Time Course of Glucagon's Effect on Glycogenolysis and Gluconeogenesis in the Conscious Dog
  499. Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog
  500. Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog.
  501. Glucose Disposal during Insulinopenia in Somatostatin-Treated Dogs
  502. Insulin Resistance